載入...
Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
BACKGROUND: Triple-negative breast cancer constitutes approximately 12%-17% of all breast cancer cases, and >33% of patients develop distant metastases. Systemic cytotoxic chemotherapy is the primary treatment for patients with metastatic triple-negative breast cancer; however, the role of first-...
Na minha lista:
| 發表在: | Technol Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8120541/ https://ncbi.nlm.nih.gov/pubmed/33977814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/15330338211016369 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|